NBTX Competitors & Alternatives
Compare Nanobiotix with similar stocks in the same industry
Biotechnology
NBTX
Main Stock$32.95
Tradestie Score
23
Market Cap
$903.54M
Revenue Growth
-0.8%
Analyst Upside
+64.4%
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.95
|
$1.78B | - | 52 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$17.99
|
$1.78B | - | 39 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$122.59
|
$1.77B | - | 57 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$31.25
|
$1.74B | - | 43 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$30.15
|
$1.68B | - | 47 | Compare |
|
MNKD
Mannkind Corporation
|
$4.19
|
$1.65B | - | 37 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$47.57
|
$1.63B | 5.6 | 40 | Compare |
|
BHVN
Biohaven Ltd.
|
$15.19
|
$1.57B | - | 42 | Compare |
|
VCEL
Vericel Corporation
|
$59.45
|
$1.56B | 92.2 | 39 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$89.30
|
$1.55B | - | 26 | Compare |
More NBTX Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
215 stocks in this industry